ArticleOncoimmunology2022
CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma.
Lihe Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it
ArticleOncoimmunology2022
Lihe Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.